THERAPEUTIC AND PHARMACOKINETIC EFFECTS OF INCREASING PHENYTOIN IN CHRONIC EPILEPTICS ON MULTIPLE DRUG THERAPY
- 1 August 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7982) , 386-389
- https://doi.org/10.1016/s0140-6736(76)92405-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976
- Anticonvulsant Drug Concentrations in Epileptic PatientsScottish Medical Journal, 1976
- OPTIMUM PHENYTOIN-DOSAGE REGIMENSThe Lancet, 1976
- PHENYTOIN DOSAGE NOMOGRAMThe Lancet, 1975
- SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSYThe Lancet, 1975
- Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma LevelsArchives of Neurology, 1974
- A gas-chromatographic method for the simultaneous determination of phenobarbitone, primidone and phenytoin in serum using a nitrogen detectorClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- Effect of dosage increments on blood phenytoin concentrationsJournal of Neurology, Neurosurgery & Psychiatry, 1972
- The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomesNeurology, 1969
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960